BDWM
BIIB icon

Brewin Dolphin Wealth Management’s Biogen BIIB Stock Holding History

Brewin Dolphin Wealth Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-60
Closed -$17K – 285
2020
Q3 		$17K Hold
60
– – ﹤0.01% 218
2020
Q2 		$16.1K Buy
+60
New +$18K ﹤0.01% 230
2018
Q3 		– Sell
-65
Closed -$18.9K – 190
2018
Q2 		$18.9K Hold
65
– – 0.01% 152
2018
Q1 		$17.8K Hold
65
– – 0.01% 149
2017
Q4 		$20.7K Buy
+65
New +$20.9K 0.01% 136

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Brewin Dolphin Wealth Management's BIIB Position: Q4 2020 in Review

Brewin Dolphin Wealth Management sold out of Biogen (BIIB) in Q4 2020, closing a stake of 60 shares — an estimated $17K sold.

Brewin Dolphin Wealth Management first reported a position in BIIB in Q4 2017 and held it in 5 quarters. The position peaked at $20.7K in Q4 2017. 1,062 funds tracked by Wall St. Rank hold BIIB as of Q4 2020.

  • Brewin Dolphin Wealth Management reported no remaining Biogen position as of Q4 2020 after selling out during the quarter.
  • Brewin Dolphin Wealth Management sold 60 Biogen shares in Q4 2020, an estimated $17K.
  • Brewin Dolphin Wealth Management first reported a position in Biogen in Q4 2017 and held it in 5 quarters.
  • Brewin Dolphin Wealth Management's Biogen position peaked at $20.7K in Q4 2017.
  • 1,062 funds tracked by Wall St. Rank held Biogen as of Q4 2020.

Based on Brewin Dolphin Wealth Management's 13F filing for Q4 2020, filed 9 Nov 2023.